Time Changes of Creatine Kinase and Creatine Kinase-MB Isoenzyme versus Discrimination Values in the Diagnosis of Acute Myocardial Infarction: What is the Optimal Method for Displaying the Data? by Lott, John A. et al.
Lott et al.: Optimum displays of serum enzymes in acute myocardial infarction - 491
Eur J Clin Chem Clin Biochem
1995; 33:491-496
© 1995 Walter de Gruyter & Co.
Berlin · New York
Time Changes of Creatine Kinase and Creatine Kinase-MB Isoenzyme
versus Discrimination Values in the Diagnosis of Acute Myocardial Infarction:
What is the Optimal Method for Displaying the Data?
By John A. Lott, John W. Heinz and Kathleen A. Reger'
Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA
(Received July 13, 1994/May 10, 1995)
Summary: We wanted to determine the optimal method for displaying data for the clinical evaluation of patients
with possible acute myocardial infarction. Our primary question was, are the time changes (slopes) of the enzyme
tests better predictors of disease than the discrimination values, i.e., the cut-off points? We studied 152 patients
with and 114 without a diagnosis of acute myocardial infarction in their medical records. For patients with acute
myocardial infarction, we found the most discriminating tests, in decreasing order of the area of the ROC curves,
to be the creatine kinase-MB slope at 0 to 12 hours, the creatine kinase-MB slope at 12 to 24 hours, the creatine
kinase-MB values between 12 and 24 hours, and the creatine kinase-MB values between 0 and 12 hours. Decreasing
values of creatine kinase-MB in the first tests after admission were only slightly less discriminating than increasing
ones. At 12 to 24 hours after admission, the total creatine kinase as a value or slope, or the "relative index" (a ratio
of the creatine kinase-MB in g/l [times 100] to the total creatine kinase) as a value or slope were inferior to
creatine kinase-MB presentations. From the data for 44 patients with acute myocardial infarction and a known time
of onset of symptoms, we were able to estimate an approximate onset time in patients where this was not available.
We recommend that changes in the creatine kinase-MB concentration with time and the values themselves should
be displayed in all patients with suspected acute myocardial infarction, and that at least three specimens should be
collected in the 24^h period after admission. Analog representation of the data along with calculated slopes facilitate
the identification of patients with possible acute myocardial infarction. The creatine-kinase-MB test has clear
limitations: several conditions have values or slopes that suggested infarction but are really something else.
Introduction
In many patients with chest pain, the diagnosis of acute gency Department, based on a non-diagnostic ECG or a
myocardial infarction cannot be made at the first contact normal creatine kinase-MB could be disastrous for the
in the Emergency Department. Diagnosing or excluding patient. Bernstein et al. (4), and Collinson et al. (5),
acute myocardial infarction in a patient with chest dis- stressed the importance of following the changes in the
comfort is a difficult problem, moreover, for "most pa- serum creatine kinase or creatine kinase-MB for about
tients, neither the history nor laboratory tests can be used 12 hours in attempting a diagnosis of acute myocardial
to exclude the possibility of infarction" (1). The electro- infarction. The same strategy can be used in most pa-
cardiogram, although specific, has a sensitivity of only tients to identify those were acute myocardial infarction
68% to 73% (2, 3). Furthermore, the best, widely avail- is unlikely. Leung et al. (6) found that discrimination
able blood test for acute myocardial infarction, creatine values or cut-off points were superior to time changes
kinase-MB isoenzyme (creatine kinase, EC 2.7.3.2), has of the values in categorizing patients with possible acute
a sensitivity of only 34% when the patient is seen early myocardial infarction; thus there is some disagreement
on (3). Clearly, premature discharges from the Emer- in the literature on how best to use the data. Of course,
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the laboratory data are only part of the information used
in the decision to admit or discharge a patient, and over-
reliance on biochemical marker^ can lead to misdiagno-
ses (7).
In view of the controversy in the literature, our first goal
was to determine how the data are best reported or dis-
played for all patients coming to the Emergency Depart-
ment with chest pain where acute myocardial infarction
is part of the differential diagnosis. We wanted to deter-
mine which of the following displays discriminated best
between patients with and without a diagnosis of acute
myocardial infarction: changes with time (slopes) or op-
timized decision point estimates for creatine kinase, cre-
atine kinase-MB, or a relative index. The relative index
is the ratio of the creatine kinase-MB in μg/l (times 100)
to the total creatine kinase. Another goal was to deter-
mine the ranges of values of the above slopes and tests
in patients with acute myocardial infarction. Finally, we
sought an estimate of the proportion of patients who
delayed coming to the Emergency Department, defined
here as those having decreasing creatine kinase-MB val-
ues with time.from the first blood specimen on.
Materials and Methods
Patient Group A
Patients with suspected acute myocardial infarction
We included all patients coming to our Emergency Department
with chest pain during a recent six-month period who had a pre-
sumptive diagnosis of possible acute myocardial infarction and
who had at least three creatine kinase and creatine kinase-MB as-
says performed in the first 24 hours after admission. A total of 266
patients were retained in the study. Blood specimens were collected
on admission and again at approximately eight and sixteen hours
later to give three collections in 24 hours. The final diagnoses were
obtained from the patients' medical records. The usual criteria for
diagnosing acute myocardial infarction and what were used at The
Ohio State University Hospitals are described elsewhere (6). We
excluded in the above patients having thoracic surgery of any kind,
balloon angioplasty, atherectomy, and any other type of invasive
cardiology within the first 24 hours after admission. We also ex-
cluded from this group those with dilated or ischemic cardiomyo-
pathy, chest trauma or chest contusions, and cocaine cardiomyopa-
thy. The time of onset of symptoms was obtained from the chart.
We accepted as valid a stated time of day for the onset but consid-
ered invalid for our purposes statements like "in the morning",
"sometime in the evening" and so on.
USA). Creatine kinase-MB values, as the mass of protein, were
determined at 37 °C by the chemiluminescent, double-antibody
immunoassay on a Corning ACS 180 analyzer (Ciba Coming Diag-
nostics Corp., Medfield, MA 02052, USA); the performance of
both tests followed the manufacturer's instructions exactly. All
tests were performed on a STAT basis with a turn-around time of
one hour or less on a 24-hour-per-day basis. Between-day profi-
ciency data for creatine kinase and creatine kinase-MB obtained in
our routine clinical chemistry laboratory are shown in table 1.
Reference values
Our upper reference intervals for creatine kinase are 232 U/l for
men and 212 U/l for women. For creatine kinase-MB and the rela-
tive index, our upper reference limit are 7 μg/I and < 1.0. respec-
tively, for both genders. The 90% sensitivity cut-off limits are
shown in table 2.
Data analysis
The changes in concentrations (or activities) of the analytes per
hour were determined exactly as described elsewhere (5). A patient
was assigned to the "negative slope group" if the creatine kinase-
MB concentration in the second specimen was less than that in the
first specimen obtained in the Emergency Department. The slope
calculated for the first time period (0 to 12 hours) included the
specimen collected on admission plus the next one, being typically
obtained 8 to 12 hours later. For the second time period (12 to 24
hours), the results from the specimens collected at 8 to 12 hours
after admission and that collected at about 16 to 24 hours post
admission were used. We chose the two 12-hour cycles post-admis-
sion based on the test ordering habits at our institution and the
findings of Puleo et al. (8), who found that obtaining maximum
sensitivities for creatine kinase-MB requires that about 12 hours
must elapse between specimen collections.
Results and Discussion
Diagnoses
In Patient group A, a total of 152 patients had a diagno-
sis of acute myocardial infarction in their medical re-
cords; of these, 74 had increasing then decreasing cre-
atine kinase-MB values, and 78 had only decreasing cre-
atine kinase-MB values during the first eight to 12 hours
post admission; the latter is a much larger proportion
than the 5 of 151 individuals with confirmed acute myo-
cardial infarction found by others (6). These authors cal-
culated the time from the onset of symptoms and used
7 to 12 hours and 13 to 18 hours as their time intervals,
Patient Group B
Patients with dilated or ischemic myopathies or
"cocaine heart"
In addition to the patients listed above, we reviewed data from 13
patients with dilated or ischemic myopathies and three patients
with "cocaine heart." We wanted to test our scheme of analyzing
the data in patients with heart disease but not acute myocardial in-
farction.
Methods
Creatine kinase assays were performed on a Kodak Ektachem 700
XR instrument at 37 °C (Eastman Kodak, Rochester, NY 14650,
Tab. 1 Between-day reproducibility of creatine kina$e and cre-
atine kinase-MB assays3

















a Creatine kinase assayed on Kodak Ektachem 700 XR and cre-
atine kinase-MB on Corning ACS 180 Analyzer.
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Test value 134 165 7.30 11.6 2.96 2.75
a Slope of first two specimens for creatine kinase-MB, i.e., at admission and at 8 to 12 hours later.
Data for group A patients only. "0" hours is time of first test in Emergency Department.


































a A positive slope occurs if the activity of the second specimen than the first specimen drawn on admission. Data are from the 44
collected eight to 12 hours after admission has a higher activity patients with known time of onset of symptoms.
hence their and our study are not directly comparable.
We found unambiguous statements in the medical re-
cords of the time of onset of symptoms in 44 of our
152 patients.
In group A with acute myocardial infarction, there were
110 men, mean age 58.4 ±11.7 (SD) years, and 42
women, mean age 62.9 ± 14.4 (SD) years. 114 patients
did not have a diagnosis of acute myocardial infarction
in their records; in some, "questionable" acute myocar-
dial infarction, "intermediate coronary syndrome", "pos-
itive subendocardial event" or "possible acute ischemia"
were present in their medical record. We elected to call
the time of the first blood specimen as time zero for all
cases with acute myocardial infarction whether the onset
time was known or not. About 71% of our patients with
acute myocardial infarction has vague or unknown on-
set times.
We recognize that patients with a significantly delayed
admission (e. g,, > 12 hours after onset) may not show
the typical increasing then decreasing creatine kinase-
MB values; however, care givers must deal with the pa-
tients as they arrive, and we have no control on how
long individuals wait to seek aid after the onset of symp-
toms. Negative initital slopes for the enzymes must also
be used in decision making where possible and be dis-
played to indicate this. Such slopes allow the approxi-
mate separation of patients into early or late arrivals in
the Emergency Department after onset of symptoms. In
table 3, we show the number of patients with a positive
slope in the specimen drawn on admission and the next
one drawn eight to 12 hours later for creatine kinase,
creatine kinase-MB, and the relative index. Our data
suggest that a delay in seeking aid is likely to result in
a negative slope for the indicated tests. In a patient with
an unknown onset time, a negative slope suggests an
onset time of > 6 hours prior to admission.
Data ranges
In the group A patients with acute myocardial infarction
tested at 12 to 24 hours after admission, 120 had creatine
kinases of > 250 U/l, 78 had > 500 U/l, and 45 had
> 1000 U/l; for each category at 0 to 12 hours, the cor-
responding number of patients were about 20% smaller.
In the non-infarct group at 12 to 24 hours, only 8 of the
Eur J Clin Chem Clin Biochem 1995; 33 (No 8)
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114 patients had creatine kinases > 500 U/l. We recom-
mend that the analog data displays use the logs of the
values or slopes, and that the y-axis be expandable to
cover the observed values.
Some patients with acute myocardial infarction and
increasing creatine kinase-MB values showed huge
changes of the creatine kinase activity per hour in the
first 24 hours: 23 had changes of > 100 U/h in the first
12 hours; 10 had like changes in the second 12 hours.
Four to five percent of the non-acute myocardial infarc-
tion patients showed slopes of this magnitude at either
time interval. Any display scheme must consider such
possible changes. At 12 to 24 hours, 87 of the 152 pa-
tients with diagnosed acute myocardial infarction had
creatine kinase-MB values > 50 μg/l, 58 had > 100 μg/l
and 23 had > 300 μg/l. For the 0 to 12 hour period,
the corresponding values are 73 patients with a creatine
kinase-MB > 50 μg/l> 45 with > 100 μg/l, and 15 with
> 300 μg/l. Like creatine kinase, the creatine kinase-
MB values were higher in the second 12-hour period
after admission. During the 12 to 24-hour period, the
change in creatine kinase-MB was > 20 μg/l · h in 98,
and > 40 μg/l · h in 82 of these 152 patients; the propor-
tion of patients with such slopes in the first 12 hours
was slightly smaller.
Receiver operating characteristics curves
The use of ROC curves to judge test accuracy is de-
scribed in detail elsewhere (9). The ROC curves for the
group A patients are here as figures la, Ib, and Ic; the
areas under the curves, SDs, and p values are given in
table 4. The area under the ROC curve for a positive
creatine kinase-MB slope within the first 12 hours is
significantly larger than the same test as a single value
within the same time interval. For the same comparisons
at 12 to 24 hours, there is no significant difference. The
slope of or the total creatine kinase and the slope of or
total relative index give essentially the same information
in all the groups; we found little advantage in calculating
the relative index.
Patients in group B with conditions
mimicking acute myocardial infarction
Nearly all the patients having invasive cardiology had
both abnormal creatine kinase-MB values and slopes
within the first 24 hours after the procedure; an early
diagnosis of acute myocardial infarction in this group is
problematic. An additional 13 patients with dilated or
ischemic cardiomyopathy all had creatine kinase-MB
values of > 7 μg/l and values above the 90% sensitivity
cut-off limit for creatine kinase-MB. The creatine ki-
nase-MB slopes were > 0.38 μg/l - h in 11 of the 13
(a)
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Percent false positive (100 - % specificity)
Fig. 1 Receiver operating characteristics plot
a) for 74 patients with acute myocardial infarction and a positive
slope of creatine kinase-MB in the first 12 hours:
+ and solid line, creatine kinase slope at 0 to 12 hours;
X and solid line; creatine kinase slope at 12 to 24 hours;
D and dashed line, creatine kinase-MB slope at 0 to 12 hours;
Ο and dashed line, creatine kinase-MB slope at 12 to 24 hours;
Δ and dotted line, relative index slope at 0 to 12 hours;
V and dotted line, relative index slope at 12 to 24 hours.
b) for 78 patients with acute myocardial infarction and a negative
slope of creatine kinase-MB in the first 12 hours.
c) for value of analyte rather than slope. Data shown for all patients
with acute myocardial infarction.
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0.781 (0.035)c 0.771 (0.034)c
0.830 (0.025)d 0.859 (0.023)
NS
0.918 (0.017) 0.797 (0.027)d 0.817 (0.025)d
a The figures (and SD) are the areas under the ROC curves shown c p < 0.01 as compared to creatine kinase-MB slope at 12 to 24
in the indicated figures and were calculated using the LABORC1 hours.
software. d p < 0.01 as compared to creatine kinase-MB value at 12 to
b p < 0.01 as compared to creatine kinase-MB slope at 0 to 12 24 hours.
hours. NS (not significant); p > 0.05 vs. adjacent creatine kinase-MB
data in table.
patients; two had values below the 90% sensitivity cut-
off limits for the slope, a small advantage. For the three
patients with cocaine poisoning and likely heart injury,
the creatine kinase-MB values were abnormal in 2 of 3,
whereas the slopes at 0 to 12 hours were all below the
90% sensitivity cut-off.
Conclusions
We conclude from our data that estimates of the change
in creatine kinase-MB per hour should be made for all
patients with suspected acute myocardial infarction, and
the analog displays of the slopes and values should be
made available. Furthermore, slope estimates for cre-
atine kinase-MB should be displayed for at least the first
24 hours after admission. Use of cut-off values for single
test results is less effective than the use of slopes in the
diagnosis of suspected acute myocardial infarction in the
first 12 hours after admission.
The areas under the ROC curves can be used to deter-
mine the accuracy of a test over the entire range of sen-
sitivity and specificity pairs (9). With this measure, cre-
atine kinase-MB slopes at 0 to 12 hours post-admission
are the most accurate. Testing patients with suspected
acute myocardial infarction for an abnormal creatine ki-
nase-MB is the current standard of care. Collinson et al.
(10) showed that the creatine kinase-MB test had
greater sensitivity than troponin T, although the latter
has the advantage of remaining abnormal for a longer
period of time (11). How the data are displayed may
very well determine how the data are used. We recom-
mend that slopes and the ordinary test results be dis-
played on computer terminals or printed to facilitate de-
cision making in patients with suspected acute myocar-
dial infarction.
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